BioSpace News Archive

Genetown

No Chemicals, Heat or Irradiation Needed for Aphios’ Viral Inactivation Tech

Aphios International is developing a generally applicable pathogen reduction technology for pooled blood plasma and blood products, immunoglobulins, recombinant biologics and monoclonal antibodies used to treat cancer and COVID-19 patients.

May 13, 2021
·
4 min read
·
Gail Dutton
Drug Development

Israeli Company Grabs $28.5 Million for Restorative Cystic Fibrosis Treatment

SpliSense, which focuses on cystic fibrosis and other genetic pulmonary diseases, closed on a $28.5 million Series B financing round. The company plans to use the money to advance its pipeline.

May 13, 2021
·
3 min read
·
Mark Terry
Biotech Bay

Research Roundup: Neuronal Cell Death in Alzheimer’s and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

May 13, 2021
·
5 min read
·
Mark Terry
FDA

The Latest News in the Battle Against COVID-19

There was a lot of news and research studies today related to the COVID-19 vaccines. Here’s a look.

May 13, 2021
·
5 min read
·
Mark Terry
Drug Development

Monoclonal Antibody Proves Worth in Asthma Study

Pivotal data from Amgen’s and AstraZeneca’s NAVIGATOR Phase III trial show tezepelumab, a potential first-in-class human monoclonal antibody, reduced asthma aggravations and exacerbations requiring hospitalizations better than placebo in patients with severe asthma.

May 13, 2021
·
3 min read
·
Brandon May
Career Advice

Do You Need an Advanced Degree in Your Field? If So, Which One?

We’ll answer these questions and a few others here in order to help you determine which path best fits your needs for the future of your biotech career.

May 13, 2021
·
3 min read
·
Kymberlie Krieger
Business

Emergent Bio Execs to Testify Before Congress Following Vaccine Manufacturing Mistake

Emergent company executives Fuad El-ibri and Robert Kramer will be testifying before a congressional probe after a botched batch of 15 million doses of J&J’s COVID-19 vaccine.

May 13, 2021
·
3 min read
·
Mark Terry
Job Trends

Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A

Significant contributions were made to the Series A by Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management.

May 13, 2021
·
2 min read
·
Brandon May
FDA

Merck’s Blockbuster Keytruda Tries Again with New Data for TNBC Approval

Merck announced positive results from the late-stage KEYNOTE-522 study that should support its previous attempt that was stymied by a regulatory advisory committee in February and rejected by the U.S. FDA in March.

May 13, 2021
·
2 min read
·
Alex Keown
Career Advice

Finding Freedom through Entrepreneurship: Startup Founder Shares Story

Have you ever thought seriously about entrepreneurship? While large organizations appear to dominate the life sciences industry, startups and small businesses have started to compete in the marketplace.

May 13, 2021
·
3 min read
·
Porschia Parker-Griffin